GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $327,000 | +3.2% | 7,506 | +3.2% | 0.03% | +13.3% |
| Q1 2022 | $317,000 | -0.3% | 7,276 | +0.9% | 0.03% | +3.4% |
| Q4 2021 | $318,000 | -66.4% | 7,210 | -70.9% | 0.03% | -67.4% |
| Q3 2021 | $946,000 | -5.5% | 24,769 | -1.4% | 0.09% | -5.3% |
| Q2 2021 | $1,001,000 | +13.4% | 25,126 | +1.5% | 0.09% | +2.2% |
| Q1 2021 | $883,000 | -5.3% | 24,753 | -2.2% | 0.09% | -13.2% |
| Q4 2020 | $932,000 | +0.9% | 25,320 | +3.1% | 0.11% | -15.9% |
| Q3 2020 | $924,000 | -4.4% | 24,550 | +3.5% | 0.13% | -11.3% |
| Q2 2020 | $967,000 | +7.6% | 23,713 | -0.0% | 0.14% | -9.6% |
| Q1 2020 | $899,000 | +6.1% | 23,717 | +31.6% | 0.16% | +9.8% |
| Q4 2019 | $847,000 | +11.0% | 18,024 | +0.9% | 0.14% | +3.6% |
| Q3 2019 | $763,000 | +11.1% | 17,870 | +4.1% | 0.14% | +7.8% |
| Q2 2019 | $687,000 | -1.4% | 17,164 | +3.0% | 0.13% | -5.9% |
| Q1 2019 | $697,000 | +10.5% | 16,668 | +1.0% | 0.14% | -5.6% |
| Q4 2018 | $631,000 | -4.1% | 16,506 | +0.8% | 0.14% | -4.0% |
| Q3 2018 | $658,000 | +0.6% | 16,374 | +0.9% | 0.15% | -14.8% |
| Q2 2018 | $654,000 | +3.6% | 16,220 | +0.4% | 0.18% | -3.3% |
| Q1 2018 | $631,000 | +11.3% | 16,160 | +1.1% | 0.18% | +22.1% |
| Q4 2017 | $567,000 | -17.7% | 15,990 | -5.8% | 0.15% | -22.4% |
| Q3 2017 | $689,000 | +4.1% | 16,980 | +10.7% | 0.19% | -2.5% |
| Q2 2017 | $662,000 | +3.4% | 15,341 | +1.1% | 0.20% | -0.5% |
| Q1 2017 | $640,000 | +7.6% | 15,181 | -1.8% | 0.20% | +12.5% |
| Q4 2016 | $595,000 | +9.4% | 15,453 | +22.6% | 0.18% | -1.1% |
| Q3 2016 | $544,000 | +11.2% | 12,608 | +11.8% | 0.18% | -1.7% |
| Q2 2016 | $489,000 | +9.4% | 11,275 | +2.3% | 0.18% | -21.3% |
| Q1 2016 | $447,000 | +33.8% | 11,017 | +32.9% | 0.23% | +37.7% |
| Q4 2015 | $334,000 | +11.3% | 8,287 | +6.3% | 0.17% | -3.5% |
| Q3 2015 | $300,000 | +50.0% | 7,798 | +62.8% | 0.17% | +73.0% |
| Q2 2015 | $200,000 | -13.8% | 4,791 | -4.9% | 0.10% | -15.3% |
| Q1 2015 | $232,000 | 0.0% | 5,037 | -7.2% | 0.12% | -4.1% |
| Q4 2014 | $232,000 | -6.8% | 5,429 | +0.1% | 0.12% | -14.0% |
| Q3 2014 | $249,000 | -17.8% | 5,421 | -4.3% | 0.14% | -17.8% |
| Q2 2014 | $303,000 | -9.8% | 5,667 | -9.8% | 0.17% | -23.7% |
| Q1 2014 | $336,000 | +0.3% | 6,283 | +0.1% | 0.23% | +14.6% |
| Q4 2013 | $335,000 | – | 6,279 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |